We launched CONTOUR®NEXT GEN blood glucose monitoring system.
About Ascensia Diabetes Care
Established in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings (formerly known as Panasonic Healthcare Holdings), Ascensia Diabetes Care is a global company entirely dedicated to improving the health and lives of people with diabetes.
Headquarter in Basel, Switzerland, Ascensia has more than 80 years history of helping people manage their diabetes. Our products are sold in more than 125 countries worldwide.
We are home to the world renowned CONTOUR® portfolio of blood glucose monitoring systems and the exclusive global distribution partner for the Eversense® continuous glucose monitoring systems from Senseonics. And we are committed to adding more innovative and life-changing products to our portfolio.
Our approach
Our goal is to provide products and solutions that make a positive, daily difference for people with diabetes. We want to make sure diabetes doesn't get in the way of people's future, enabling them to live richer lives.
Why CONTOUR® meter systems?
Our range of products combines state-of-the-art technology with user-friendly functionality that supports diabetes management, providing clear and accurate readings you can trust.
Through our technology we look to make diabetes management as simple as possible to get the data you need to make informed decisions, and provide systems that make monitoring easier and well-suited to modern living.
Our history
For more than 80 years, continuous research has allowed our team to lead the way in the development of blood glucose monitoring technology and systems. These innovations have been designed to not only meet the needs of patients, but to help simplify and improve their lives.
-
2022
-
We became the exclusive global distribution partner for the Eversense® continuous glucose monitoring systems from Senseonics.
2020
-
We launched a smarter version of our CONTOUR®DIABETES app with new features to support self-management for people with diabetes
2018
-
Ascensla Diabetes Care was established through the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings Co., Ltd
2016
-
We introduced the first in line of the portfolio of CONTOUR®NEXT blood glucose meters, our next generation of highly accurate diabetes management products
2011
-
We introduced a suite of blood glucose monitors with No Coding® technology, including BREEZE® and CONTOUR® meters
2003
-
We introduced Glucometer Elite® the first meter to use ‘sip-in’ technology and the first ‘low volume' (3 microliter) blood glucose monitoring system
1993
-
Through the former Ames division, we Introduced the Ames Reflectance Meter, the first portable blood glucose meter
1969
-
We developed Clinitest®, the first conveniez tablet test for measurement of reducing substances in urine, such as glucose.
1941
Proud Supporters Of
